Scotiabank Remains a Hold on Apellis Pharmaceuticals (APLS)
Scotiabank analyst Greg Harrison maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of ...
CN price target lowered to C$166 from C$176 at Scotiabank
Scotiabank analyst Konark Gupta lowered the firm’s price target on CN (CNI) to C$166 from C$176 and keeps an Outperform rating on the ...
Bank of Nova Scotia stock rises Wednesday, outperforms market
Bank of Nova Scotia closed 15.0% below its 52-week high of C$80.14, which the company reached on December 2nd.
Between The Posts20hOpinion
Autocracy to Prevail at Sportsnet
TORONTO (Apr. 1) — What the MAGA man wants, the MAGA man gets.